Mark Merritt, the CEO of Pharmaceutical Care Management Association, the trade association that represents pharmacy benefits managers like Express Scripts, which recently partnered with Imprimis to provide its compounded version of Daraprim at a cheaper cost, made it very clear that he would rather see generic competition than compounded versions.

Senate committee fumes over drug price hikes, mocks Turing's Shkreli

Ars Technica-8 minutes ago

One temporary solution is to use compounded drugs, witness Mark Merritt, president and CEO of the Pharmaceutical Care Management Association, told the ...

The Senate just got closer to figuring out how to stop people like ...
Business Insider-1 hour ago

Explore in depth (185 more articles)